-transparent.png){kind=logo}
Ribavirin was found to inhibit five strains of HVH/2 tested in KB cells with the M1C range being 10-100 microgram/ml. In a mouse tail animal model, it effectively reduced HVH/2-induced lesions particularly at the peak lesion periods. Ribavirin was remarkably effective when intravaginal treatment was initiated late in the infection, which suggests that it may have potential for treatment of human cutaneous infections.
Related Publications
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
December 1975,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
January 1986,
Journal of perinatal medicine,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
January 1991,
Clinical and experimental obstetrics & gynecology,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
January 1973,
Archiv fur die gesamte Virusforschung,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
September 1973,
Antimicrobial agents and chemotherapy,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
April 1971,
Obstetrics and gynecology,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
November 1984,
Die Pharmazie,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
November 1975,
Obstetrics and gynecology,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
January 1972,
Bollettino dell'Istituto sieroterapico milanese,
L B Allen, and
S M Wolf, and
C J Hintz, and
J H Huffman, and
R W Sidwell
September 1978,
Canadian Medical Association journal,
